Correlation Between Catalyst Pharmaceuticals and Eastern
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Eastern at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Eastern into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Eastern Co, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Eastern and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Eastern. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Eastern.
Diversification Opportunities for Catalyst Pharmaceuticals and Eastern
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Catalyst and Eastern is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Eastern Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eastern and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Eastern. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eastern has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Eastern go up and down completely randomly.
Pair Corralation between Catalyst Pharmaceuticals and Eastern
Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.84 times more return on investment than Eastern. However, Catalyst Pharmaceuticals is 1.19 times less risky than Eastern. It trades about 0.05 of its potential returns per unit of risk. Eastern Co is currently generating about -0.04 per unit of risk. If you would invest 2,044 in Catalyst Pharmaceuticals on September 15, 2024 and sell it today you would earn a total of 94.00 from holding Catalyst Pharmaceuticals or generate 4.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Catalyst Pharmaceuticals vs. Eastern Co
Performance |
Timeline |
Catalyst Pharmaceuticals |
Eastern |
Catalyst Pharmaceuticals and Eastern Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Catalyst Pharmaceuticals and Eastern
The main advantage of trading using opposite Catalyst Pharmaceuticals and Eastern positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Eastern can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eastern will offset losses from the drop in Eastern's long position.Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
Eastern vs. Timken Company | Eastern vs. Lincoln Electric Holdings | Eastern vs. Hillman Solutions Corp | Eastern vs. AB SKF |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |